1. Home
  2. PTCT vs LPL Comparison

PTCT vs LPL Comparison

Compare PTCT & LPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • LPL
  • Stock Information
  • Founded
  • PTCT 1998
  • LPL 1985
  • Country
  • PTCT United States
  • LPL South Korea
  • Employees
  • PTCT N/A
  • LPL N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • LPL Industrial Machinery/Components
  • Sector
  • PTCT Health Care
  • LPL Technology
  • Exchange
  • PTCT Nasdaq
  • LPL Nasdaq
  • Market Cap
  • PTCT 3.9B
  • LPL 3.4B
  • IPO Year
  • PTCT 2013
  • LPL 2004
  • Fundamental
  • Price
  • PTCT $48.55
  • LPL $3.40
  • Analyst Decision
  • PTCT Buy
  • LPL Sell
  • Analyst Count
  • PTCT 14
  • LPL 2
  • Target Price
  • PTCT $63.57
  • LPL N/A
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • LPL 221.8K
  • Earning Date
  • PTCT 08-07-2025
  • LPL 07-24-2025
  • Dividend Yield
  • PTCT N/A
  • LPL N/A
  • EPS Growth
  • PTCT N/A
  • LPL N/A
  • EPS
  • PTCT 7.51
  • LPL N/A
  • Revenue
  • PTCT $1,772,758,000.00
  • LPL $18,624,457,609.00
  • Revenue This Year
  • PTCT $121.50
  • LPL N/A
  • Revenue Next Year
  • PTCT N/A
  • LPL N/A
  • P/E Ratio
  • PTCT $6.45
  • LPL N/A
  • Revenue Growth
  • PTCT 91.12
  • LPL 23.70
  • 52 Week Low
  • PTCT $29.02
  • LPL $2.43
  • 52 Week High
  • PTCT $58.38
  • LPL $4.86
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 46.94
  • LPL 50.93
  • Support Level
  • PTCT $47.52
  • LPL $3.30
  • Resistance Level
  • PTCT $49.73
  • LPL $3.45
  • Average True Range (ATR)
  • PTCT 1.46
  • LPL 0.09
  • MACD
  • PTCT -0.19
  • LPL -0.02
  • Stochastic Oscillator
  • PTCT 36.28
  • LPL 27.14

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.

Share on Social Networks: